Nextech Invest
Overview
Nextech Invest is a global investment manager founded 1998 and located in Zurich, Switzerland. With its unique oncology-focused funds, Nextech Invest is a dedicated investor in leading oncology companies developing cancer drugs and diagnostics. Nextech Invest benefits from the support of an active and committed Scientific Advisory Board of highly influential oncology advisors, chaired by David Livingston, MD, deputy director at the Dana-Farber Cancer Institute/Harvard Cancer Center.
Investment Focus
- Evidence of preclinical efficacy
- Potential for multiple medicines
- Focus on oncology therapeutics
- Strong management team
- Clear exit strategy within three years
Portfolio Companies
Reach Nextech Invest directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Nextech Invest
What sectors does Nextech Invest invest in?
Nextech Invest invests in Healthcare, Life Sciences, Pharmaceuticals, Medical Devices, Diagnostics and Biotechnology, and is based in Zurich, Zurich, Switzerland. Nextech Invest is listed as a vc in the ConnectSafely investor database.
What stage does Nextech Invest invest at?
Nextech Invest backs companies at Early Stage and Late Stage, writing cheques of 1M - 5M.
Which regions does Nextech Invest invest in?
Nextech Invest invests across United States, United Kingdom, Germany, France, Italy and Denmark.
Who are the partners at Nextech Invest?
Team members listed for Nextech Invest include Marco Weibel (Chief Financial Officer) and Thilo Schroeder (Managing Partner).
What companies has Nextech Invest invested in?
Nextech Invest's portfolio includes Peloton Therapeutics, Revolution Medicines, Arvinas, Autolus, Kronos, Agensys, Ganymed and MacroGenics.
How do I contact Nextech Invest?
Nextech Invest's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
